Tricuspid regurgitation is a heart valve condition where blood leaks backward from the right ventricle into the right atrium during each heartbeat. A trace amount of this backflow is extremely common and usually harmless. Mild tricuspid regurgitation is detectable in over 80% of adults on imaging. Moderate to severe cases affect roughly 3% of the general population, rising to about 7% in people over 75.
How the Tricuspid Valve Works
The tricuspid valve sits between the two chambers on the right side of your heart: the right atrium (which receives blood returning from your body) and the right ventricle (which pumps that blood to your lungs). The valve has three thin flaps, or leaflets, anchored by cord-like structures called chordae tendineae that connect to small muscles inside the ventricle wall.
When the right ventricle contracts to push blood toward the lungs, those small muscles tighten the cords so the three leaflets press firmly together, forming a seal. This prevents blood from flowing the wrong direction. In tricuspid regurgitation, that seal is incomplete, and some blood escapes back into the right atrium instead of moving forward to the lungs.
One interesting detail: the severity of the leak changes with breathing. When you inhale, the right ventricle widens slightly, stretching the ring of tissue that supports the valve. This increases the gap between the leaflets and temporarily worsens the backflow.
Primary vs. Secondary Causes
Doctors divide tricuspid regurgitation into two broad categories based on what’s causing it.
Primary tricuspid regurgitation means the valve itself is damaged. This is less common. Causes include infections of the heart valve (endocarditis), rheumatic heart disease, connective tissue disorders that weaken the leaflets, certain medications, chest trauma, or congenital heart defects. Pacemaker or defibrillator leads that pass through the valve can also interfere with how the leaflets close.
Secondary (or functional) tricuspid regurgitation is far more common and accounts for the majority of cases. Here, the valve leaflets themselves are structurally normal, but the heart around them has changed shape. When the right ventricle enlarges from conditions like heart failure, pulmonary hypertension, or atrial fibrillation, the ring of tissue supporting the valve stretches. The leaflets can no longer reach each other to form a tight seal. Left-sided heart valve problems, particularly mitral valve disease, frequently lead to secondary tricuspid regurgitation because the increased pressure backs up into the right side of the heart.
Symptoms to Recognize
Mild tricuspid regurgitation rarely causes any symptoms. Most people with a trace or mild leak never know they have it unless it shows up incidentally on an echocardiogram done for another reason.
As the leak worsens, the right atrium and right ventricle have to handle extra volume with every beat. Over time, this overloads the right side of the heart and raises pressure in the veins that return blood from the rest of your body. The resulting symptoms are all related to this venous congestion:
- Swelling in the legs, ankles, or feet from fluid backing up into the lower body
- Abdominal swelling (ascites) as fluid accumulates in the belly
- Visible pulsing in the neck veins, especially a prominent wave with each heartbeat
- Fatigue and exercise intolerance because less blood moves forward to the lungs and the rest of the body
- Liver enlargement and tenderness, sometimes with jaundice in advanced cases, because venous congestion backs up into the liver
- Unintentional weight loss and muscle wasting in severe, longstanding disease
An irregular heartbeat (atrial fibrillation) frequently accompanies moderate to severe cases, both as a cause and a consequence. Because these symptoms develop gradually, many people attribute them to aging or other conditions, which often delays diagnosis.
How It’s Diagnosed
A standard transthoracic echocardiogram (a painless ultrasound of the heart) is the primary tool for detecting and grading tricuspid regurgitation. The test uses color Doppler imaging to visualize the jet of blood flowing backward through the valve, and technicians measure its width and area to estimate severity.
One key measurement is the vena contracta, the narrowest width of the leaking jet as it passes through the valve. A vena contracta of 7 mm or more indicates severe regurgitation, while measurements of 14 to 20 mm are classified as massive and 21 mm or greater as torrential.
When echocardiogram results are unclear or the leak appears severe, cardiac MRI offers a more detailed look. It provides high-resolution images of the valve, the right ventricle’s size and function, and can even detect scarring in the heart muscle. For some patients, a right heart catheterization (a thin tube threaded through a vein to directly measure pressures inside the heart) may be recommended to confirm how much strain the leak is placing on the right side of the heart. This is particularly useful when planning an intervention.
How Severity Is Graded
Tricuspid regurgitation is categorized on a spectrum. Trace and mild leaks are considered normal variants and don’t require treatment. Moderate regurgitation warrants monitoring. Severe regurgitation, and the newer categories of massive and torrential, carry meaningful health consequences.
In a study of adults with an average age of about 80, 62% had no or trivial regurgitation, 29% had mild, 7% had moderate, and 1% had severe. Prevalence and severity both increase with age, even within an older population. Women are slightly more likely than men to have detectable leaks on imaging, though the clinical significance of mild leaks is minimal regardless of sex.
Treatment Approaches
Treatment depends on the severity of the leak and whether it’s primary or secondary.
Medical Management
For secondary tricuspid regurgitation, the first priority is treating whatever is causing the right side of the heart to enlarge. That means managing heart failure, controlling atrial fibrillation, or addressing pulmonary hypertension. Diuretics (water pills) are the cornerstone of symptom relief, helping reduce fluid overload and ease swelling, abdominal bloating, and breathlessness. For many patients, this is the only treatment needed, and the regurgitation may improve as the underlying condition stabilizes.
Surgical and Catheter-Based Options
Surgery on the tricuspid valve is most commonly performed during the same operation as left-sided valve surgery. Current guidelines recommend tricuspid valve repair or replacement for patients undergoing mitral or aortic valve surgery who also have significant tricuspid regurgitation, or even moderate regurgitation with a stretched valve ring (40 mm or greater in diameter).
Isolated tricuspid valve surgery, meaning surgery done solely for the tricuspid valve, is considered for patients with severe primary regurgitation and right-sided heart failure that isn’t responding to medications. Timing matters: outcomes are better when surgery happens before the right ventricle becomes severely weakened or the liver and kidneys sustain lasting damage.
Newer catheter-based (percutaneous) procedures have emerged as options for patients who are too high-risk for open surgery. These involve threading devices through a vein to clip the valve leaflets together or implant a replacement valve, without opening the chest.
Long-Term Outlook
Mild tricuspid regurgitation has an excellent prognosis and typically doesn’t progress. Severe isolated tricuspid regurgitation, however, carries significant long-term risk regardless of how it’s treated.
A recent meta-analysis found that patients with severe tricuspid regurgitation managed with medications alone had mortality rates of 14% at one year, 20% at two years, and 46% at five years. Patients who underwent surgery had an 8% in-hospital mortality rate, with five-year mortality of 30%. Catheter-based procedures had a lower in-hospital mortality of about 1%, but two-year mortality reached 22%, similar to the other groups. Notably, after adjusting for differences between patients, no treatment strategy showed a clear survival advantage over the others at the two-year mark.
These numbers reflect the reality that severe tricuspid regurgitation often coexists with advanced heart failure, pulmonary hypertension, and other serious conditions. The leak itself contributes to a vicious cycle: as more blood flows backward, the right ventricle works harder and stretches further, which worsens the leak, which stretches the ventricle more. Breaking that cycle early, before irreversible damage sets in, gives patients the best chance at preserving heart function and quality of life.